CIK: 1427569 - Address: C/O Ngm Biopharmaceuticals, Inc., 333 Oyster Point Boulevard, South San Francisco, CA 94080
23 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
S%ret115-2-5-6-16-300-12
S%wins601006010010084

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
2/3/21 17:37
2/1/21
CHRSCoherus Biosciences, Inc.DEHealthBioPrdBiological Products, (No DiagViret Jean-FredericCAOCFOS.d-16021.550-7-1161D
1/27/21 16:15
1/25/21
CHRSCoherus Biosciences, Inc.DEHealthBioPrdBiological Products, (No DiagViret Jean-FredericCAOCFOS.d-92119.950-46-4361D
11/19/20 16:16
11/17/20
CHRSCoherus Biosciences, Inc.DEHealthBioPrdBiological Products, (No DiagViret Jean-FredericCAOCFOS.d-3517.490-2-540D
10/16/20 16:19
10/14/20
CHRSCoherus Biosciences, Inc.DEHealthBioPrdBiological Products, (No DiagViret Jean-FredericCAOCFOS-11719.000-6-1340D
5/22/20 16:30
5/20/20
CHRSCoherus Biosciences, Inc.DEHealthBioPrdBiological Products, (No DiagViret Jean-FredericCAOCFOS-2317.660-1-347D
2/21/20 18:16
2/19/20
CHRSCoherus Biosciences, Inc.DEHealthBioPrdBiological Products, (No DiagViret Jean-FredericCAOCFOS.d-7122.330-3-647D
1/17/20 16:11
1/15/20
CHRSCoherus Biosciences, Inc.DEHealthBioPrdBiological Products, (No DiagViret Jean-FredericCAOCFOS.d-12519.850-6-1247D
11/22/19 16:09
11/20/19
CHRSCoherus Biosciences, Inc.DEHealthBioPrdBiological Products, (No DiagViret Jean-FredericCAOCFOS.d-6219.590-3-493D
11/20/19 16:22
11/18/19
CHRSCoherus Biosciences, Inc.DEHealthBioPrdBiological Products, (No DiagViret Jean-FredericCAOCFOS-5918.880-3-493D
10/22/19 16:06
10/18/19
CHRSCoherus Biosciences, Inc.DEHealthBioPrdBiological Products, (No DiagViret Jean-FredericCAOCFOS-2619.020-1-186D
10/18/19 16:05
10/16/19
CHRSCoherus Biosciences, Inc.DEHealthBioPrdBiological Products, (No DiagViret Jean-FredericCAOCFOS.d-6019.000-3-298D
9/25/19 16:05
9/23/19
CHRSCoherus Biosciences, Inc.DEHealthBioPrdBiological Products, (No DiagViret Jean-FredericCAOCFOS-1621.780-1-98D
9/20/19 16:05
9/18/19
CHRSCoherus Biosciences, Inc.DEHealthBioPrdBiological Products, (No DiagViret Jean-FredericCAOCFOS.d-6520.440-3-279D
8/23/19 16:05
8/21/19
CHRSCoherus Biosciences, Inc.DEHealthBioPrdBiological Products, (No DiagViret Jean-FredericCAOCFOS.d-13721.710-6-439D
8/21/19 16:05
8/19/19
CHRSCoherus Biosciences, Inc.DEHealthBioPrdBiological Products, (No DiagViret Jean-FredericCAOCFOS-5719.040-3-269D
6/20/19 16:05
6/18/19
CHRSCoherus Biosciences, Inc.DEHealthBioPrdBiological Products, (No DiagViret Jean-FredericCAOCFOS.dm-13619.850-7-3712D
3/22/19 16:05
3/20/19
CHRSCoherus Biosciences, Inc.DEHealthBioPrdBiological Products, (No DiagViret Jean-FredericCAOCFOS-4514.920-3-1913D
7/25/18 16:05
7/23/18
CHRSCoherus Biosciences, Inc.DEHealthBioPrdBiological Products, (No DiagViret Jean-FredericCAOCFOS-17218.560-9-714D
1/27/17 16:06
1/25/17
CHRSCoherus Biosciences, Inc.DEHealthBioPrdBiological Products, (No DiagViret Jean-FredericCAOCFOS.d-10527.008-4-573D241027-100-2951-3-18-28
12/20/16 16:05
12/16/16
CHRSCoherus Biosciences, Inc.DEHealthBioPrdBiological Products, (No DiagViret Jean-FredericCAOCFOS.d-11028.308-4-573D1112477-12900000-7-19
11/22/16 16:05
11/18/16
CHRSCoherus Biosciences, Inc.DEHealthBioPrdBiological Products, (No DiagViret Jean-FredericCAOCFOS.d-11028.1915-4-632D119356-50223101-21
10/25/16 16:05
10/21/16
CHRSCoherus Biosciences, Inc.DEHealthBioPrdBiological Products, (No DiagViret Jean-FredericCAOCFOS.d-11930.6211-4-632D24502432183-3-10-9-9-34
9/28/16 16:05
9/26/16
CHRSCoherus Biosciences, Inc.DEHealthBioPrdBiological Products, (No DiagViret Jean-FredericCAOCFOS.d-11729.8813-4-632D3761986200-9-113-3-26

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact